相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Discovery of SY-5609: A Selective, Noncovalent Inhibitor of CDK7
Jason J. Marineau et al.
JOURNAL OF MEDICINAL CHEMISTRY (2022)
Structure-activity relationship study of THZ531 derivatives enables the discovery of BSJ-01-175 as a dual CDK12/13 covalent inhibitor with efficacy in Ewing sarcoma
Baishan Jiang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
Targeting CDK7 suppresses super enhancer-linked inflammatory genes and alleviates CAR T cell-induced cytokine release syndrome
Ye Wei et al.
MOLECULAR CANCER (2021)
Structure and noncanonical Cdk8 activation mechanism within an Argonaute-containing Mediator kinase module
Yi-Chuan Li et al.
SCIENCE ADVANCES (2021)
Discovery and resistance mechanism of a selective CDK12 degrader
Baishan Jiang et al.
NATURE CHEMICAL BIOLOGY (2021)
SY-5609, a highly potent and selective oral CDK7 inhibitor, exhibits robust antitumor activity in preclinical models of KRAS mutant cancers as a single agent and in combination with chemotherapy
S. H. Henry et al.
ANNALS OF ONCOLOGY (2021)
Safety and efficacy of VIP152, a CDK9 inhibitor, in patients with double-hit lymphoma (DHL).
Victor Moreno et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
CRISPR screening identifies CDK12 as a conservative vulnerability of prostate cancer
Hanqi Lei et al.
CELL DEATH & DISEASE (2021)
Modulating Androgen Receptor-Driven Transcription in Prostate Cancer with Selective CDK9 Inhibitors
Andre Richters et al.
CELL CHEMICAL BIOLOGY (2021)
Inhibition of the transcriptional kinase CDK7 overcomes therapeutic resistance in HER2-positive breast cancers
Bowen Sun et al.
ONCOGENE (2020)
AZD4573 Is a Highly Selective CDK9 Inhibitor That Suppresses MCL-1 and Induces Apoptosis in Hematologic Cancer Cells
Justin Cidado et al.
CLINICAL CANCER RESEARCH (2020)
CDK7 Inhibition Potentiates Genome Instability Triggering Anti-tumor Immunity in Small Cell Lung Cancer
Hua Zhang et al.
CANCER CELL (2020)
A novel CDK9 inhibitor increases the efficacy of venetoclax (ABT-199) in multiple models of hematologic malignancies
Darren C. Phillips et al.
LEUKEMIA (2020)
CDK7 Inhibition Is Effective in all the Subtypes of Breast Cancer: Determinants of Response and Synergy with EGFR Inhibition
Martina S. J. McDermott et al.
CELLS (2020)
Selective Mediator dependence of cell-type-specifying transcription
Martin G. Jaeger et al.
NATURE GENETICS (2020)
CDK11 is required for transcription of replication-dependent histone genes
Pavla Gajduskova et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2020)
Potent anti-tumor activity of AUR102, a selective covalent inhibitor of CDK7
L.K. Satyam et al.
EUROPEAN JOURNAL OF CANCER (2020)
Discovery of AZD4573, a Potent and Selective Inhibitor of CDK9 That Enables Short Duration of Target Engagement for the Treatment of Hematological Malignancies
Bernard Barlaam et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Super-enhancer in prostate cancer: transcriptional disorders and therapeutic targets
Xuanrong Chen et al.
NPJ PRECISION ONCOLOGY (2020)
Inhibition of CDK9 by voruciclib synergistically enhances cell death induced by the Bcl-2 selective inhibitor venetoclax in preclinical models of acute myeloid leukemia
Daniel A. Luedtke et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Efficacy of combined CDK9/13ET inhibition in preclinical models of MLL-rearranged acute leukemia
Hannah McCalmont et al.
BLOOD ADVANCES (2020)
Discovery and Characterization of SY-1365, a Selective, Covalent Inhibitor of CDK7
Shanhu Hu et al.
CANCER RESEARCH (2019)
The complete structure of the human TFIIH core complex
Basil J. Greber et al.
ELIFE (2019)
Structural basis of TFIIH activation for nucleotide excision repair
Goran Kokic et al.
NATURE COMMUNICATIONS (2019)
CDK12 loss in cancer cells affects DNA damage response genes through premature cleavage and polyadenylation
Malgorzata Krajewska et al.
NATURE COMMUNICATIONS (2019)
CDK7 Inhibition Suppresses Castration-Resistant Prostate Cancer through MED1 Inactivation
Reyaz Ur Rasool et al.
CANCER DISCOVERY (2019)
Systemic Toxicity Reported for CDK8/19 Inhibitors CCT251921 and MSC2530818 Is Not Due to Target Inhibition
Mengqian Chen et al.
CELLS (2019)
A kinase inhibitor screen identifies a dual cdc7/CDK9 inhibitor to sensitise triple-negative breast cancer to EGFR-targeted therapy
Ronan P. McLaughlin et al.
BREAST CANCER RESEARCH (2019)
Cdk7: a kinase at the core of transcription and in the crosshairs of cancer drug discovery
Robert P. Fisher
TRANSCRIPTION-AUSTIN (2019)
Human CDK12 and CDK13, multi-tasking CTD kinases for the new millenium
Arno L. Greenleaf
TRANSCRIPTION-AUSTIN (2019)
Inhibition of CDK7 overcomes resistance to CDK4/6 inhibitors in hormone receptor positive breast cancer cells
C. Guarducci et al.
CANCER RESEARCH (2019)
Transcription regulation by the Mediator complex
Julie Soutourina
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2018)
Suppression of Adaptive Responses to Targeted Cancer Therapy by Transcriptional Repression
Maria Rusan et al.
CANCER DISCOVERY (2018)
Cyclin-dependent kinase 7 (CDK7)-mediated phosphorylation of the CDK9 activation loop promotes P-TEFb assembly with Tat and proviral HIV reactivation
Uri Mbonye et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
ICEC0942, an Orally Bioavailable Selective Inhibitor of CDK7 for Cancer Treatment
Hetal Patel et al.
MOLECULAR CANCER THERAPEUTICS (2018)
Small Molecules Co-targeting CKIα and the Transcriptional Kinases CDK7/9 Control AML in Preclinical Models
Waleed Minzel et al.
CELL (2018)
Phase I dose escalation study of the first-in-class selective PTEFb inhibitor BAY 1251152 in patients with advanced cancer: Novel target validation and early evidence of clinical activity.
Jennifer Robinson Diamond et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Structure of paused transcription complex Pol II-DSIF-NELF
Seychelle M. Vos et al.
NATURE (2018)
Selective gene dependencies in MYCN-amplified neuroblastoma include the core transcriptional regulatory circuitry
Adam D. Durbin et al.
NATURE GENETICS (2018)
Targeting CDK9 Reactivates Epigenetically Silenced Genes in Cancer
Hanghang Zhang et al.
CELL (2018)
Phase I Study of the PTEFb Inhibitor BAY 1251152 in Patients with Acute Myelogenous Leukemia
Michael Byrne et al.
BLOOD (2018)
7SK small nuclear RNA, a multifunctional transcriptional regulatory RNA with gene-specific features
Sylvain Egloff et al.
TRANSCRIPTION-AUSTIN (2018)
Preclinical Efficacy and Molecular Mechanism of Targeting CDK7-Dependent Transcriptional Addiction in Ovarian Cancer
Zhenfeng Zhang et al.
MOLECULAR CANCER THERAPEUTICS (2017)
CDK12 regulates alternative last exon mRNA splicing and promotes breast cancer cell invasion
Jerry F. Tien et al.
NUCLEIC ACIDS RESEARCH (2017)
SEL120-34A is a novel CDK8 inhibitor active in AML cells with high levels of serine phosphorylation of STAT1 and STAT5 transactivation domains
Tomasz Rzymski et al.
ONCOTARGET (2017)
Human TFIIH Kinase CDK7 Regulates Transcription-Associated Chromatin Modifications
Christopher C. Ebmeier et al.
CELL REPORTS (2017)
Identification of Atuveciclib (BAY 1143572), the First Highly Selective, Clinical PTEFb/CDK9 Inhibitor for the Treatment of Cancer
Ulrich Luecking et al.
CHEMMEDCHEM (2017)
Cyclin-dependent kinase 9 is a novel specific molecular target in adult T-cell leukemia/lymphoma
Tomoko Narita et al.
BLOOD (2017)
Transcriptional Dependencies in Diffuse Intrinsic Pontine Glioma
Surya Nagaraja et al.
CANCER CELL (2017)
Transcriptional Addiction in Cancer
James E. Bradner et al.
CELL (2017)
Covalent targeting of remote cysteine residues to develop CDK12 and CDK13 inhibitors
Tinghu Zhang et al.
NATURE CHEMICAL BIOLOGY (2016)
Identification of Mediator Kinase Substrates in Human Cells using Cortistatin A and Quantitative Phosphoproteomics
Zachary C. Poss et al.
CELL REPORTS (2016)
Assessing the mechanism and therapeutic potential of modulators of the human Mediator complex-associated protein kinases
Paul A. Clarke et al.
ELIFE (2016)
The Molecular Taxonomy of Primary Prostate Cancer
Adam Abeshouse et al.
CELL (2015)
Characterization of Human Cyclin-Dependent Kinase 12 (CDK12) and CDK13 Complexes in C-Terminal Domain Phosphorylation, Gene Transcription, and RNA Processing
Kaiwei Liang et al.
MOLECULAR AND CELLULAR BIOLOGY (2015)
THZ1 Reveals Roles for Cdk7 in Co-transcriptional Capping and Pausing
Kyle A. Nilson et al.
MOLECULAR CELL (2015)
Mediator kinase inhibition further activates super-enhancer-associated genes in AML
Henry E. Pelish et al.
NATURE (2015)
The androgen receptor cistrome is extensively reprogrammed in human prostate tumorigenesis
Mark M. Pomerantz et al.
NATURE GENETICS (2015)
The history and future of targeting cyclin-dependent kinases in cancer therapy
Uzma Asghar et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
CDK9 inhibitors define elongation checkpoints at both ends of RNA polymerase II-transcribed genes
Clelia Laitem et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2015)
CDK9 inhibitors define elongation checkpoints at both ends of RNA polymerase II-transcribed genes
Clelia Laitem et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2015)
Estimating scenarios for survival time in men starting systemic therapies for castration-resistant prostate cancer: A systematic review of randomised trials
T. A. West et al.
EUROPEAN JOURNAL OF CANCER (2014)
TFIIH Phosphorylation of the Pol II CTD Stimulates Mediator Dissociation from the Preinitiation Complex and Promoter Escape
Koon Ho Wong et al.
MOLECULAR CELL (2014)
Targeting transcription regulation in cancer with a covalent CDK7 inhibitor
Nicholas Kwiatkowski et al.
NATURE (2014)
Cyclin-dependent kinases
Marcos Malumbres
GENOME BIOLOGY (2014)
Promoter clearance by RNA polymerase II
Donal S. Luse
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2013)
Cyclin-dependent kinase inhibitor therapy for hematologic malignancies
Prithviraj Bose et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2013)
CDK10/cyclin M is a protein kinase that controls ETS2 degradation and is deficient in STAR syndrome
Vincent J. Guen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Pause, play, repeat CDKs push RNAP II's buttons
Miriam Sanso et al.
TRANSCRIPTION-AUSTIN (2013)
The RNA polymerase II CTD coordinates transcription and RNA processing
Jing-Ping Hsin et al.
GENES & DEVELOPMENT (2012)
Role of Ser7 phosphorylation of the CTD during transcription of snRNA genes
Sylvain Egloff
RNA BIOLOGY (2012)
The phosphorylation of the androgen receptor by TFIIH directs the ubiquitin/proteasome process
Pierre Chymkowitch et al.
EMBO JOURNAL (2011)
RNAP II CTD Phosphorylated on Threonine-4 Is Required for Histone mRNA 3′ End Processing
Jing-Ping Hsin et al.
SCIENCE (2011)
CDK9 Regulates AR Promoter Selectivity and Cell Growth through Serine 81 Phosphorylation
Vicki Gordon et al.
MOLECULAR ENDOCRINOLOGY (2010)
The Development of a Selective Cyclin-Dependent Kinase Inhibitor That Shows Antitumor Activity
Simak Ali et al.
CANCER RESEARCH (2009)
CDK9 directs H2B monoubiquitination and controls replication-dependent histone mRNA 3′-end processing
Judith Pirngruber et al.
EMBO REPORTS (2009)
Cotranscriptionality: The Transcription Elongation Complex as a Nexus for Nuclear Transactions
Roberto Perales et al.
MOLECULAR CELL (2009)
Site-specific androgen receptor serine phosphorylation linked to epidermal growth factor-dependent growth of castration-recurrent prostate cancer
Liliana A. Ponguta et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Characterization of cyclin L1 and L2 interactions with CDK11 and splicing factors - Influence of cyclin L isoforms on splice site selection
Pascal Loyer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Nucleotide excision repair driven by the dissociation of CAK from TFIIH
Frederic Coin et al.
MOLECULAR CELL (2008)
Expression of the TMPRSS2:ERG fusion gene predicts cancer recurrence after surgery for localised prostate cancer
R. K. Nam et al.
BRITISH JOURNAL OF CANCER (2007)
Recognition of trimethylated histone h3 lysine 4 facilitates the recruitment of transcription postinitiation factors and pre-mRNA splicing
Robert J. Sims et al.
MOLECULAR CELL (2007)
Cyclin D3/CDK11p58 complex is involved in the repression of androgen receptor
Hongliang Zong et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
P-TEFb-mediated phosphorylation of hSpt5 C-terminal repeats is critical for processive transcription elongation
T Yamada et al.
MOLECULAR CELL (2006)
Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer
SA Tomlins et al.
SCIENCE (2005)
Recruitment of P-TEFb for stimulation of transcriptional elongation by the bromodomain protein brd4
ZY Yang et al.
MOLECULAR CELL (2005)
Androgen receptor in prostate cancer
CA Heinlein et al.
ENDOCRINE REVIEWS (2004)
Phosphorylation of serine 2 within the RNA polymerase IIC-terminal domain couples transcription and 3′ end processing
SH Ahn et al.
MOLECULAR CELL (2004)
Inhibition of P-TEFb (CDK9/Cyclin T) kinase and RNA polymerase II transcription by the coordinated actions of HEXIM1 and 7SK snRNA
JHN Yik et al.
MOLECULAR CELL (2003)
Cdk10, a Cdc2-related kinase, associates with the Ets2 transcription factor and modulates its transactivation activity
M Kasten et al.
ONCOGENE (2001)
Structural basis of preinitiation complex assembly on human Pol II promoters
FTF Tsai et al.
EMBO JOURNAL (2000)
分享论文
